(Q37667487)

English

Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review

scientific article published on April 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

Independent and combined effects of aerobic exercise and pharmacological strategies on serum triglyceride concentrations: a qualitative review (English)

1 reference

Europe PubMed Central

21 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Eric P Plaisance

1

1 reference

Europe PubMed Central

21 August 2017

Peter W Grandjean

2

1 reference

Europe PubMed Central

21 August 2017

A Jack Mahurin

3

1 reference

Europe PubMed Central

21 August 2017

language of work or name

0 references

publication date

1 April 2009

1 reference

Europe PubMed Central

21 August 2017

The Physician and Sportsmedicine

1 reference

Europe PubMed Central

21 August 2017

37

1 reference

Europe PubMed Central

21 August 2017

1

1 reference

Europe PubMed Central

21 August 2017

11-19

1 reference

Europe PubMed Central

21 August 2017

High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Hypertriglyceridemia: its etiology, effects and treatment

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Plasma triglyceride level and mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Atherogenesis: a postprandial phenomenon

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Exercise and postprandial lipid metabolism: an update on potential mechanisms and interactions with high-carbohydrate diets (review)

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Lipids, lipoproteins, and exercise

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Blood lipid and lipoprotein adaptations to exercise: a quantitative analysis

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Changes in LPLa and reverse cholesterol transport variables during 24-h postexercise period

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Effect of prolonged exercise training without weight loss on high-density lipoprotein metabolism in overweight men.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Moderate exercise, postprandial lipaemia and triacylglycerol clearance.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

New perspectives on the use of niacin in the treatment of lipid disorders

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Evaluation of effects of unmodified niacin on fasting and postprandial plasma lipids in normolipidemic men with hypoalphalipoproteinemia.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Niacin mediates lipolysis in adipose tissue through its G-protein coupled receptor HM74A

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Niacin and cholesterol: role in cardiovascular disease (review).

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Nicotinic acid: an old drug with a promising future

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Niacin stimulates adiponectin secretion through the GPR109A receptor

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Influence of extended-release nicotinic acid on nonesterified fatty acid flux in the metabolic syndrome with atherogenic dyslipidemia

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Increased total and high-molecular weight adiponectin after extended-release niacin

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

The biochemistry of n-3 polyunsaturated fatty acids

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

The independent and combined effects of aerobic exercise and dietary fish intake on serum lipids and glycemic control in NIDDM. A randomized controlled study.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Interaction of exercise training and n-3 fatty acid supplementation on postprandial lipemia.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Tissue-specific regulation of lipoprotein lipase activity by insulin/glucose in normal-weight humans

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

The effect of dietary fish oil on muscle and adipose tissue lipoprotein lipase

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Efficacy of alternate day versus daily dosing of rosuvastatin

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

A comparison of the effects of fluvastatin and bezafibrate on exercise metabolism: a placebo-controlled study in healthy normolipidaemic subjects

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Effects of exercise training on conduit and resistance vessel function in treated and untreated hypercholesterolaemic subjects.

1 reference

https://api.crossref.org/works/10.3810%2FPSM.2009.04.1678

21 January 2018

Identifiers

10.3810/PSM.2009.04.1678

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37667487&oldid=2169689696"